Skip to content

A prospective, multi-center clinical study to verify the accuracy of the automatic GTV delineation method for head and neck squamous cell carcinoma based on deep learning

A prospective, multi-center clinical study to verify the accuracy of the automatic GTV delineation method for head and neck squamous cell carcinoma based on deep learning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081110
Enrollment
Unknown
Registered
2024-02-22
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck Cancer

Interventions

Gold Standard:Target volume used for clinical radiotherapy (The primary lesion target area delineated by experts)
Index test:Deep learning generates primary lesion target area (GTV) on T1 enhanced MRI

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) No gender limit, age ranges from 18 to 75 years old; 2) Pathologically confirmed newly treated head and neck squamous cell carcinoma (oral cavity, oropharynx, larynx, hypopharynx, paranasal sinuses, etc.); 3) Patients who plan to undergo radical radiotherapy and have completed target area delineation; 4) Patients who have both positioning CT and enhanced MRI within a week when delineating the target area; 5) Can understand this research.

Exclusion criteria

Exclusion criteria: 1) When delineating the target area, positioning CT and MRI were not fused and delineated simultaneously in TPS; 2) Patients whose target area has not been delineated or reviewed by a senior physician (deputy chief physician or above); 3) Patients whose MRI image quality is too poor will affect the delineation of the target area.

Design outcomes

Primary

MeasureTime frame
DSC;HD95;ASD;Accuracy;

Countries

China

Contacts

Public ContactWenjun Liao

Sichuan Cancer Hospital

lwjpsy@163.com+86 182 8016 7590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026